[Research Report] The biopharmaceutical contract manufacturing market is projected to reach US$ 27,868.50 million by 2028 from US$ 15,735.04 million in 2021; it is expected to grow at a CAGR of 8.5% from 2021 to 2028.
The rising outsourcing by pharmaceutical companies is one of the most key factors driving the growth of the market. A few years ago, the contract manufacturing industry was a niche service market offering additional manufacturing capacity or specific services to pharmaceutical companies. The rise of CMOs was fueled by the increasing number of drug manufacturing failures. In the past, pharmaceutical companies had undertaken manufacturing facilities to develop innovative drugs. However, to reduce the risk of overcapacities, the demand for manufacturing outsourcing has continuously risen. Recently, Revolo Biotherapeutics entered into a partnership with contract development and manufacturing organization (CDMO)—Northway Biotech—to manufacture Revolo’s binding immuno-regulatory protein 1805. The partnership included services from cell line development to manufacturing protein with quality assurance and regulatory compliance support. Similarly, Gland Pharma has been manufacturing Remdesivir for four companies, including Mylan, since 2021. Also, the organization increased its manufacturing quotas due to high demand from the companies. In 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under this agreement, Samsung Biologics was providing services ranging from f-cell lines development to production of Phase-I drug substances. The increasing number of contracts between biopharmaceutical companies and contract manufacturing companies shows an increasing market size for the biopharmaceutical contract manufacturing market.
North America is likely to continue its dominance in the biopharmaceutical contract manufacturing market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. Increasing demand for clinical trials, growing pharmaceutical and medical device industries, increasing healthcare expenditure, high R&D spending, and the presence of key market players in the region that offer manufacturing, storage, logistic, and other services is likely to enhance the market growth in the country. For instance, Alderley Analytical, Almac, and among others are well-known manufacturing organizations that offer a wide range of integrated services to more than 600 pharmaceutical and biotech companies. The presence and significant impact of biopharmaceutical companies in the region in terms of revenue, technology, and employment opportunities are expected to aid the growth of the market in the region.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Contract Manufacturing Market: Strategic Insights
Market Size Value in US$ 15,735.04 million in 2021 Market Size Value by US$ 27,868.50 million by 2028 Growth rate CAGR of 8.5% from 2021 to 2028. Forecast Period 2021- 2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Contract Manufacturing Market: Strategic Insights
| Market Size Value in | US$ 15,735.04 million in 2021 |
| Market Size Value by | US$ 27,868.50 million by 2028 |
| Growth rate | CAGR of 8.5% from 2021 to 2028. |
| Forecast Period | 2021- 2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Biopharmaceutical Contract Manufacturing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Demand for Biologics Drives Market Growth
The contract manufacturing market for biologics is growing at an unprecedented rate owing to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus towards core activities. Presently, many pharmaceutical and biotechnology companies outsource varied services from early-stage drug development to commercial-scale manufacturing. Outsourcing is required to expedite research and development, speed up market entry, give access to novel technologies, regulatory expertise, and reduce risks at a competitive cost. Complexities in biologics development and production and increasingly stringent quality standards have driven drug manufacturers to prefer contract manufacturer services. Moreover, many companies are opting CMOs services to speed up the development process and lower production costs. For instance, Sanofi has outsourced manufacturing of its biologics pipeline to Boehringer Ingelheim. Moreover, TaiMed Biologics Ibalizumab (the FDA-designated orphan drug) is manufactured by CMO WuXi PharmaTech. Also, in 2021, Samsung Biologics expanded its collaboration with AstraZeneca from 2020. The contract included the production of a drug substance, AstraZeneca’s COVID-19 long-acting antibody combination, and manufacturing of a cancer immunotherapy product started from 2022.
Product-Based Insights
Based on product, biopharmaceuticals contract manufacturing market is segmented into biosimilar and biologics. The biologics segment held the largest share of the market in 2021 owing to increasing demand for biologics, increasing research, and development activities to develop new drugs for chronic indications in the forecast period. The segment is further segmented into monoclonal antibodies, recombinant proteins, vaccines, and others. The market for biosimilar is expected to register the highest CAGR in the market during the forecast period due to patent expiration of blockbuster drugs and increasing pipeline.
Biopharmaceutical Contract Manufacturing Market, by Product– 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Service Insights
The biopharmaceuticals contract manufacturing market, by service, is segmented into process development, fill and finish operations, analytical and quality control studies, and packaging. In 2021, the process development accounted for the largest market share in the global biopharmaceuticals contract manufacturing market owing to higher focus on pilot to commercial scale-up process development, cell line development, and other processes. However, analytical and quality control studies are expected to grow at a significant CAGR in the forecast period owing to stringent regulatory regulation and complex manufacturing requirements for biologics.
Companies operating in the biopharmaceutical contract manufacturing market adopt product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. Also, the companies in the market create partnerships, collaborations, and contracts with biopharmaceutical companies to further drive the revenue of the market.
Biopharmaceutical Contract Manufacturing Market – Segmentation
Based on the product, the biopharmaceutical contract manufacturing market is segmented into biologics and biosimilar. The biologics segment is further segmented into monoclonal antibodies, recombinant proteins, vaccines, and others.
By service, the biopharmaceutical contract manufacturing market is segmented into process development, fill and finish operations, analytical and quality control studies, and packaging.
Based on the source, the biopharmaceutical contract manufacturing market is segmented into mammalian and microbial-based biologics/non-mammalian.
Biopharmaceutical Contract Manufacturing Market – by Geography
Based on geography, the biopharmaceutical contract management market is primarily segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European biopharmaceutical contract management market is sub-segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. The market in the Asia Pacific is sub-segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The biopharmaceutical contract management market in the Middle East and Africa is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East and Africa. The market in South and Central America is sub-segmented into Brazil, Argentina, and the Rest of South and Central America.
Company Profiles
- Lonza AG
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Inno Bio Ventures Sdn Bhd
- Thermo Fisher Scientific, Inc.
- AbbVie, Inc.
- WuXi Biologics, Inc.
- General Electric Co.
- Samsung Biologics Co. Ltd.
- Merck KGaA
- Ajinomoto Co. Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product; Service, and Source, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Biopharmaceuticals contract manufacturing refers to biopharmaceutical companies outsourcing the development and manufacturing of drugs substances and products to contract manufacturers with the necessary resources to manufacture their products. Biopharmaceutical contract manufacturing organizations (CMOs) have become a known name among pharmaceutical companies due to their cost effective services that require minimal capital investments by the biopharmaceutical company. The CMOs offer a wide range of services including process development, analytical and quality control studies, fill and finish operations, and packaging. Moreover, the growing biopharma industry is offering lucrative opportunities for the growth of the market.
The factors that are driving the growth of the market are increasing demand for biologics, growing biosimilar pipelines, stringent regulatory guidelines, and increasing outsourcing by pharmaceutical companies. Moreover, emerging markets are offering lucrative opportunities owing to the increasing number of contract manufacturers in developing countries.
The biopharmaceutical contract manufacturing market majorly consists of the players such as Lonza AG, Boehringer Ingelheim Biopharmaceuticals GmbH, Inno Bio Ventures Sdn Bhd, Thermo Fisher Scientific, Inc., AbbVie, Inc., WuXi Biologics, Inc., General Electric Co., Samsung Biologics Co. Ltd., Merck KGaA, and Ajinomoto Co. Inc., among others.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biopharmaceutical Contract Manufacturing Market – By Product
1.3.2 Global Biopharmaceutical Contract Manufacturing Market – By Service
1.3.3 Global Biopharmaceutical Contract Manufacturing Market – By Source
1.3.4 Global Biopharmaceutical Contract Manufacturing Market – By Geography
2. Biopharmaceutical Contract Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Biopharmaceutical Contract Manufacturing – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Outsourcing by Pharmaceutical Companies
5.1.2 Increasing Demand for Biologics
5.2 Market Restraints
5.2.1 Growing Competition in Industry
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Consolidation in Pharmaceutical CMO Industry
5.4.2 COVID-19 Pandemic
5.5 Impact Analysis
6. Biopharmaceutical Contract Manufacturing Market – Global Analysis
6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis
6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Biopharmaceuticals Contract Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)
7.3 Biologics
7.3.1 Overview
7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Monoclonal Antibodies
7.3.2.1.1 Overview
7.3.2.1.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Recombinant Proteins
7.3.2.2.1 Overview
7.3.2.2.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Vaccines
7.3.2.3.1 Overview
7.3.2.3.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Others
7.3.2.4.1 Overview
7.3.2.4.2 Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Biosimilar
7.4.1 Overview
7.4.2 Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8. Biopharmaceuticals Contract Manufacturing Market – By Service
8.1 Overview
8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)
8.3 Process Development
8.3.1 Overview
8.3.2 Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Downstream Processing
8.3.2.1.1 Overview
8.3.2.1.2 Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Upstream Processing
8.3.2.2.1 Overview
8.3.2.2.2 Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Fill and Finish Operations
8.4.1 Overview
8.4.2 Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Analytical and Quality Control Studies
8.5.1 Overview
8.5.2 Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Packaging
8.6.1 Overview
8.6.2 Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9. Biopharmaceuticals Contract Manufacturing Market – By Source
9.1 Overview
9.2 Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)
9.3 Mammalian-Based Biologics
9.3.1 Overview
9.3.2 Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Microbial/Non-Mammalian-Based Biologics
9.4.1 Overview
9.4.2 Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10. Biopharmaceutical Contract Manufacturing Market – Geographic Analysis
10.1 North America: Biopharmaceutical Contract Manufacturing Market
10.1.1 Overview
10.1.2 North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.3.1 North America: Biologics Market, 2019-2028 (USD Million)
10.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.4.1 North America: Process Development Market, 2019-2028 (USD Million)
10.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.1.2.1 US: Biologics Market, 2019-2028 (USD Million)
10.1.6.1.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.1.3.1 US: Process Development Market, 2019-2028 (USD Million)
10.1.6.1.4 US: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6.2 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.2.2.1 Canada: Biologics Market, 2019-2028 (USD Million)
10.1.6.2.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.2.3.1 Canada: Process Development Market, 2019-2028 (USD Million)
10.1.6.2.4 Canada: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6.3 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.3.2.1 Mexico: Biologics Market, 2019-2028 (USD Million)
10.1.6.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.3.3.1 Mexico: Process Development Market, 2019-2028 (USD Million)
10.1.6.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2 Europe: Biopharmaceutical Contract Manufacturing Market
10.2.1 Overview
10.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.3.1 Europe: Biologics Market, 2019-2028 (USD Million)
10.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.4.1 Europe: Process Development Market, 2019-2028 (USD Million)
10.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.1.2.1 Germany: Biologics Market, 2019-2028 (USD Million)
10.2.6.1.3 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.1.3.1 Germany: Process Development Market, 2019-2028 (USD Million)
10.2.6.1.4 Germany: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.2 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.2.2.1 UK: Biologics Market, 2019-2028 (USD Million)
10.2.6.2.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.2.3.1 UK: Process Development Market, 2019-2028 (USD Million)
10.2.6.2.4 UK: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.3 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.3.2.1 France: Biologics Market, 2019-2028 (USD Million)
10.2.6.3.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.3.3.1 France: Process Development Market, 2019-2028 (USD Million)
10.2.6.3.4 France: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.4 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.4.2.1 Spain: Biologics Market, 2019-2028 (USD Million)
10.2.6.4.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.4.3.1 Spain: Process Development Market, 2019-2028 (USD Million)
10.2.6.4.4 Spain: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.5 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.5.2.1 Italy: Biologics Market, 2019-2028 (USD Million)
10.2.6.5.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.5.3.1 Italy: Process Development Market, 2019-2028 (USD Million)
10.2.6.5.4 Italy: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.6.2.1 Rest of Europe: Biologics Market, 2019-2028 (USD Million)
10.2.6.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.6.3.1 Rest of Europe: Process Development Market, 2019-2028 (USD Million)
10.2.6.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market
10.3.1 Overview
10.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.3.1 Asia Pacific: Biologics Market, 2019-2028 (USD Million)
10.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.4.1 Asia Pacific: Process Development Market, 2019-2028 (USD Million)
10.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.1.2.1 China: Biologics Market, 2019-2028 (USD Million)
10.3.6.1.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.1.3.1 China: Process Development Market, 2019-2028 (USD Million)
10.3.6.1.4 China: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.2 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.2.2.1 Japan: Biologics Market, 2019-2028 (USD Million)
10.3.6.2.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.2.3.1 Japan: Process Development Market, 2019-2028 (USD Million)
10.3.6.2.4 Japan: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.3 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.3.2.1 India: Biologics Market, 2019-2028 (USD Million)
10.3.6.3.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.3.3.1 India: Process Development Market, 2019-2028 (USD Million)
10.3.6.3.4 India: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.4 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.4.2.1 South Korea: Biologics Market, 2019-2028 (USD Million)
10.3.6.4.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.4.3.1 South Korea: Process Development Market, 2019-2028 (USD Million)
10.3.6.4.4 South Korea: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.5 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.5.2.1 Australia: Biologics Market, 2019-2028 (USD Million)
10.3.6.5.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.5.3.1 Australia: Process Development Market, 2019-2028 (USD Million)
10.3.6.5.4 Australia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.6.2.1 Rest of Asia Pacific: Biologics Market, 2019-2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific: Process Development Market, 2019-2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.3.1 Middle East & Africa: Biologics Market, 2019-2028 (USD Million)
10.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.4.1 Middle East & Africa: Process Development Market, 2019-2028 (USD Million)
10.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)
10.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.1.2.1 Saudi Arabia: Biologics Market, 2019-2028 (USD Million)
10.4.6.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.1.3.1 Saudi Arabia: Process Development Market, 2019-2028 (USD Million)
10.4.6.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.2 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.2.2.1 UAE: Biologics Market, 2019-2028 (USD Million)
10.4.6.2.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.2.3.1 UAE: Process Development Market, 2019-2028 (USD Million)
10.4.6.2.4 UAE: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.3 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.3.2.1 South Africa: Biologics Market, 2019-2028 (USD Million)
10.4.6.3.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.3.3.1 South Africa: Process Development Market, 2019-2028 (USD Million)
10.4.6.3.4 South Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.4.2.1 Rest of Middle East and Africa: Biologics Market, 2019-2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.4.3.1 Rest of Middle East and Africa: Process Development Market, 2019-2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5 South and Central America: Biopharmaceutical Contract Manufacturing Market
10.5.1 Overview
10.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.3.1 South and Central America: Biologics Market, 2019-2028 (USD Million)
10.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.4.1 South and Central America: Process Development Market, 2019-2028 (USD Million)
10.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.1.2.1 Brazil: Biologics Market, 2019-2028 (USD Million)
10.5.6.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.1.3.1 Brazil: Process Development Market, 2019-2028 (USD Million)
10.5.6.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6.2 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.2.2.1 Argentina: Biologics Market, 2019-2028 (USD Million)
10.5.6.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.2.3.1 Argentina: Process Development Market, 2019-2028 (USD Million)
10.5.6.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.3.2.1 Rest of South and Central America: Biologics Market, 2019-2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.3.3.1 Rest of South and Central America: Process Development Market, 2019-2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Biopharmaceutical Contract Manufacturing Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 General Electric Company
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGAA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lonza
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Samsung Biologics
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AbbVie Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 WUXI BIOLOGICS
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ajinomoto Co. Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Inno Bio Ventures Sdn Bhd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. North America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 6. US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 7. US Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 8. US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 9. US Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 10. US Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 21. Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 22. Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 26. Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 27. Germany Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 28. Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 30. Germany Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 31. UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 32. UK Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 33. UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 34. UK Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 35. UK Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 36. France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 37. France Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 38. France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 39. France Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 40. France Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 41. Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 42. Spain Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 43. Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 44. Spain Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 45. Spain Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 46. Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 47. Italy Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 48. Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 49. Italy Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 50. Italy Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 61. China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 62. China Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 63. China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 64. China Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 65. China Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 71. India: R&D spending of Pharmaceutical companies (2010 & 2017)
Table 72. India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 73. India Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 74. India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 75. India Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 76. India Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 81. South Korea Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 86. Australia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 96. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 101. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 106. UAE Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 111. South Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 121. South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 126. Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 131. Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 136. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 137. Organic Developments Done By Companies
Table 138. Inorganic Developments Done By Companies
Table 139. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market
LIST OF FIGURES
Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation
Figure 2. Biopharmaceutical Contract Manufacturing Segmentation, By Region
Figure 3. Global Biopharmaceutical Contract Manufacturing Market Overview
Figure 4. Biologics Segment Held Largest Share Of Product In Biopharmaceutical Contract Manufacturing Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Biopharmaceutical Contract Manufacturing Market, By Geography (US$ Million)
Figure 7. Global Biopharmaceutical Contract Manufacturing Market- Leading Country Markets (US$ Million)
Figure 8. Global Biopharmaceutical Contract Manufacturing Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints
Figure 15. Global Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028
Figure 16. Global Biopharmaceutical Contract Manufacturing Market – By Geography Forecast And Analysis – 2019- 2028
Figure 17. Market Positioning Of Key Players In Global Biopharmaceutical Contract Manufacturing Market
Figure 18. Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)
Figure 19. Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)
Figure 26. Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)
Figure 33. Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)
Figure 37. North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
Figure 38. US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Projection of the Use of Pharmaceutical Products in Mexico (Million Dollars)
Figure 41. Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)
Figure 43. Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)
Figure 44. Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
Figure 45. Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)
Figure 52. Asia Pacific Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
Figure 54. China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)
Figure 61. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)
Figure 62. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)
Figure 63. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)
Figure 68. South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
Figure 70. Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. IMPACT OF COVID-19 PANDEMIC IN NORTH AMERICAN COUNTRY MARKETS
Figure 74. IMPACT OF COVID-19 PANDEMIC IN EUROPEAN COUNTRY MARKETS
Figure 75. IMPACT OF COVID-19 PANDEMIC IN ASIA-PACIFIC COUNTRY MARKETS
Figure 76. IMPACT OF COVID-19 PANDEMIC IN MIDDLE EAST AND AFRICAN COUNTRY MARKETS
Figure 77. IMPACT OF COVID-19 PANDEMIC IN SOUTH AND CENTRAL AMERICAN COUNTRY MARKETS
Figure 78. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Biopharmaceuticals Contract Manufacturing Market
- Lonza AG
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Inno Bio Ventures Sdn Bhd
- Thermo Fisher Scientific, Inc.
- AbbVie, Inc.
- WuXi Biologics, Inc.
- General Electric Co.
- Samsung Biologics Co. Ltd.
- Merck KGaA
- Ajinomoto Co. Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Biopharmaceutical Contract Manufacturing Market
Feb 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)